Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
38.4M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$359M
-
Value change
-
-$41.6M
-
Put/Call ratio
-
0.2
-
Number of buys
-
68
-
Number of sells
-
-31
-
Price
-
$9.36
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2021
114 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.4M shares
of 69M outstanding shares and own 55.66% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.41M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3M shares), BlackRock Inc. (2.3M shares), Cormorant Asset Management, LP (2.17M shares), RA CAPITAL MANAGEMENT, L.P. (2.15M shares), VANGUARD GROUP INC (2.15M shares), WELLINGTON MANAGEMENT GROUP LLP (2.02M shares), Vivo Capital, LLC (1.69M shares), and CITADEL ADVISORS LLC (1.43M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.